Skip to main content

BRIEF RESEARCH REPORT article

Front. Cell. Infect. Microbiol., 13 January 2022
Sec. Biofilms
This article is part of the Research Topic Women in Biofilms 2021 View all 12 articles

mazEF Homologue Has a Minor Role in Staphylococcus epidermidis 1457 Virulence Potential

  • 1Laboratory of Research in Biofilms Rosário Oliveira, Centre of Biological Engineering, University of Minho, Braga, Portugal
  • 2Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
  • 3Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal
  • 4Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Porto, Portugal

Staphylococcus epidermidis biofilm cells are characterized by increased antimicrobial tolerance and improved ability to evade host immune system defenses. These features are, in part, due to the presence of viable but non-culturable (VBNC) cells. A previous study identified genes potentially involved in VBNC cells formation in S. epidermidis biofilms, among which SERP1682/1681 raised special interest due to their putative role as a toxin–antitoxin system of the mazEF family. Herein, we constructed an S. epidermidis mutant lacking the mazEF genes homologues and determined their role in (i) VBNC state induction during biofilm formation, (ii) antimicrobial susceptibility, (iii) survival in human blood and plasma, and (iv) activation of immune cells. Our results revealed that mazEF homologue did not affect the proportion of VBNC cells in S. epidermidis 1457, refuting the previous hypothesis that mazEF homologue could be linked with the emergence of VBNC cells in S. epidermidis biofilms. Additionally, mazEF homologue did not seem to influence key virulence factors on this strain, since its deletion did not significantly affect the mutant biofilm formation capacity, antimicrobial tolerance or the response by immune cells. Surprisingly, our data suggest that mazEF does not behave as a toxin–antitoxin system in S. epidermidis strain 1457, since no decrease in the viability and culturability of bacteria was found when only the mazF toxin homologue was being expressed.

Introduction

Staphylococcus epidermidis, a commensal bacterium that is a common inhabitant of the skin and mucous membranes of humans and several mammals, is recognized by its ability to form thick and multi-layered biofilms, especially on the surface of indwelling medical devices (Fey and Olson, 2011). Although S. epidermidis generally presents a benign relationship with the host, this species has been considered an opportunistic pathogen particularly affecting preterm neonates and immunocompromised patients and is now considered one of the main causes of medical device-associated infections (Otto, 2009).

Previous in vitro studies have shown that S. epidermidis biofilms present an increased tolerance to antibiotics (Cerca et al., 2005; Anderson and O’Toole, 2008) and to the host immune response (Brescó et al., 2017; Nguyen et al., 2017), which may hinder the treatment of biofilm-associated infections. Moreover, S. epidermidis cells can enter a state of dormancy, either becoming persisters (Shapiro et al., 2011) or viable but non-culturable (VBNC) (Zandri et al., 2012). The presence of high amounts of VBNC cells can hamper the routine detection or interpretation of the actual status of the infection (Zandri et al., 2012). Furthermore, VBNC cells within S. epidermidis biofilms account for a greater ability to evade the host innate immune system (Cerca et al., 2011a) and decreased susceptibility to antibiotics (Cerca et al., 2014).

Following an in vitro model that induces VBNC cells in S. epidermidis biofilms (Cerca et al., 2011a), the transcriptome of biofilms with higher amounts of VBNC cells was characterized. Among the genes of interest identified, SERP1682, a mazE homologue, raised special interest since it was uniquely detected when the VBNC state was induced (Carvalhais et al., 2014). Importantly, the mazEF gene family has been described as a toxin–antitoxin (TA) system and is composed of genes that encode a stable toxin (mazF) and a labile antitoxin (mazE) (Van Melderen, 2010), which are involved in the regulation of essential cell processes (Karimi et al., 2015). These genes were first described as a TA system in E. coli (Metzger et al., 1988). Nevertheless, the function of this module as a TA system has been experimentally confirmed in other species such as Streptococcus mutans (Syed et al., 2011), S. aureus (Zhu et al., 2009), and S. equorum (Schuster et al., 2013). Furthermore, several homology studies indicate the presence of the putative mazEF TA complex in other species, such as Pseudomonas aeruginosa (Valadbeigi et al., 2017), Mycobacterium tuberculosis (Tiwari et al., 2015), and S. epidermidis (Behrooz et al., 2018). However, so far, the role of mazEF homologue in S. epidermidis virulence has not been determined. As such, herein, we constructed and characterized a mazEF homologue mutant strain.

Material and Methods

Strains and Growth Media

S. epidermidis 1457 (Mack et al., 1992) was used in this study. The wild type (WT) and constructs were grown overnight in Tryptic Soy Broth (TSB, Merck) at 37°C and with agitation at 120 rpm. In the case of strains harboring the plasmids pRB473 or pRMC2, TSB supplemented with 10 μg/ml chloramphenicol was used (TSBCM10). For further experiments, the overnight cultures were diluted in TSB or TSBCM10 to an optical density (OD) of 0.250 ± 0.05 at 640 nm, corresponding to approximately 2 × 108 colony-forming units/ml (CFU/ml) (Freitas et al., 2014).

Mutant Construction

Genetic manipulations were based on previous protocols (Brückner, 1997; Monk et al., 2012). Briefly, the flanking regions of the mazEF homologue operon were amplified and linked together by an overlap PCR. The resulting fragment was ligated into the plasmid pIMAY and transformed into E. coli DC10B, where the correct sequence and orientation of the flanking regions were confirmed by sequencing. The knockout plasmid was then transformed into the WT strain by electroporation (Monk et al., 2012; Cui et al., 2015). The allelic replacement protocol was performed as described in Monk et al. (2012) and the confirmation of the deletion of the mazEF homologue operon was done by PCR. Then, the ΔmazEF mutant was transformed with two distinct plasmids: the pRB473 (Bruckner et al., 1993) and the pRMC2 inducible plasmid (Corrigan and Foster, 2009). In brief, the homologous sequences of the genes mazE, mazF or the operon mazEF were amplified and cloned into pRB473 (sequences cloned included the target genes and their natural promoter region) or pRMC2 (sequences cloned included a strong ribosomal binding site and start and stop codons). While the plasmid pRB473 was first transformed into E. coli DC10B, the inducible plasmid pRMC2 was first transformed into S. aureus RN4220. Finally, the expression plasmids were inserted into ΔmazEF mutant strain by electroporation. The successful restoration of mazE/mazF/mazEF homologues expression was performed by qPCR, as described below. The primers used herein were designed using Primer3 software (Untergasser et al., 2012) and are listed in Supplementary Table 1.

Induction of mazEF Expression

The optimal conditions to induce the pRMC2 plasmid were first assessed by evaluating the effect of different concentrations of anhydrotetracycline (ATC, 0.64 and 1.28 μg/ml) or tetracycline (TET, 0.08 and 0.16 μg/ml), both purchased from Sigma-Aldrich, in the culturability of ΔmazEF cells. Thereafter, the induction of the expression of the genes cloned into the inducible plasmid (mazE, mazF or mazEF homologues) was started by adjusting the overnight cultures of each construct to an OD640nm = 0.5, followed by a 1:10 dilution in 10 ml of TSBCM10 and incubation for 3 h at 37°C and 120 rpm. Then, 0.64 μg/ml of ATC was added, and the tubes were incubated under the same temperature and agitation conditions for up to 24 h. A tube without ATC was used as a control. Aliquots were collected at the beginning of the induction (T = 0 h), after 30, 60, 90, 120, 180, and 240 min and at the end of the experiment (T = 24 h) to measure the OD and quantify the number of culturable cells.

Planktonic Growth and Biofilm Formation

A suspension with approximately 2 × 108 CFU/ml, prepared as described above, was used to start both planktonic cultures and biofilms. Planktonic cultures were started by inoculating 100 μl of this suspension into 10 ml of TSB/TSBCM10 and further incubated at 37°C and 120 rpm, for up to 24 h. Biofilms were formed as described before in either 24-well plates (for VBNC state assessment, confocal analysis and gene expression studies) (Cerca et al., 2011a; Carvalhais et al., 2014) or 96-well plates (for antimicrobial assays) (Oliveira et al., 2015). Of note, for confocal analysis, biofilms were formed on Nunc™ thermanox™ coverslips (Thermo Fisher Scientific) that were placed inside the wells. After 48 h of growth, biofilms were washed twice and either stained (for confocal analysis) or scraped from the plate bottom, in 0.9% NaCl, and submitted to a pulse of sonication of 10 s at 33% amplitude (Cole-Parmer), to dissociate cells clusters but without interfering with cell viability (Freitas et al., 2014). The amount of planktonic and biofilm cells was then quantified by OD640nm and CFU counting. Moreover, for VBNC state-modulated biofilms, the total number of viable cells was also assessed by flow cytometry as previously optimized (Cerca et al., 2011b). The gating strategy is represented in Supplementary Figure 1A. Additionally, their structure was analyzed by confocal laser scanning microscopy (CLSM) using wheat germ agglutinin (WGA), which binds PNAG and allows the detection of the matrix, and DAPI, which stains nucleic acids and allows cells visualization (Cerca et al., 2006).

Gene Expression

To quantify the expression levels of the genes cloned into the plasmid pRMC2, planktonic cultures induced for 4 h with 0.64 μg/ml ATC were used. For the quantification of gene expression in 48 hour-old biofilms, biofilm cells were collected as described above and, then, pooled together to decrease variability (Sousa et al., 2014). One milliliter of both planktonic or biofilm cells pool was used for RNA isolation with the kit ExtractMe RNA Bacteria & Yeast (Blirt S.A.) and as optimized before for S. epidermidis (França et al., 2012). RNA was treated with DNase and RNA concentration and purity were assessed using NanoDrop One (Thermo Fisher Scientific). Subsequently, RNA was reverse transcribed using the RevertAid H minus M-Mulv RT enzyme (Thermo Fisher Scientific) and quantitative PCR (qPCR) reactions prepared using Xpert Fast SYBR Mastermix (GRiSP). Finally, samples were run in a CFX96 thermal cycler (Bio-Rad) with the following cycle parameters: 95°C for 2 min, and 40 cycles of 95°C for 5 s, 60°C for 30 s. No-template and no-reverse transcriptase controls were included to evaluate, respectively, reagents and RNA contamination with genomic DNA. The absence of unspecific products and primer dimers was assessed by analysis of melting curves. Primers were designed with Primer3 (Untergasser et al., 2012) using S. epidermidis 1457 genome as the template (Supplementary Table 2).

Antimicrobial Tolerance

The susceptibility to antibiotics was evaluated upon 6 and 24 h of incubation through CFU counting and by the reduction of tetrazolium salt XTT, which estimates cells metabolic activity, as described before (Cerca et al., 2005). Briefly, 2 ml of TSB supplemented with the peak serum concentrations (PSC) of vancomycin (40 μg/ml) (VWR), tetracycline (16 μg/ml), and rifampicin (10 μg/ml) (all purchased from Sigma-Aldrich) were inoculated with 1 × 107 CFU/ml of bacteria in the stationary phase (24-hour growth). In the case of biofilms, 200 µl of TSB supplemented with PSC of the antibiotics under study were added to 48 hour-old biofilms grown in 96-well plates. Both planktonic and biofilm populations were incubated at 37°C and 120 rpm for up to 24 h.

Survival in Human Blood and Plasma

Plasma was separated by centrifugation of whole blood for 20 min at 1,440g and 4°C. The co-incubation of bacteria with either whole blood, plasma or TSB supplemented with heparin (TSB + heparin, control) was performed as described before (França et al., 2016; Brás et al., 2020). Briefly, 50 µl of bacterial suspensions with 2 × 105 CFU/ml were mixed with 450 µl of whole blood, plasma or TSB + heparin and incubated at 37°C and 80 rpm for up to 4 h. Cells culturability was assessed at the beginning of the assay (T = 0 h) and 1, 2, and 4 h after incubation.

Dendritic Cells and Macrophages Differentiation

Peripheral blood mononuclear cells (PBMC) were isolated from buffy coats through density gradient centrifugation (1,200g for 15 min), using Histopaque 1077 (Sigma-Aldrich) in SepMate PBMC isolation tubes (Stemcell Technologies). CD14+ cells were isolated using anti-human CD14 MicroBeads (Miltenyi Biotec), according to manufacturer’s instructions and, then, suspended in complete RPMI medium—RPMI 1640 (Sigma-Aldrich) supplemented with 10% Fetal Bovine Serum (Biowest), 4 mM L-glutamine (Sigma-Aldrich), 10 mM HEPES (Sigma-Aldrich), and 50 μM β-mercaptoethanol (Merck) and seeded on 6-well culture plates at a concentration of 1 × 106 cells/ml. Granulocyte–macrophage colony-stimulating factor (GM-CSF) (50 ng/ml) and macrophage colony-stimulating factor (M-CSF) (50 ng/ml) were used to differentiate monocytes into M1- and M2-like macrophages, respectively. To differentiate monocytes into dendritic cells (DC), GM-CSF (50 ng/ml) and interleukin-4 (50 ng/ml) were used. All cell cultures were incubated at 37°C with 5% CO2 for 7 days. Every 3 days, half of the cell culture medium was replaced with fresh complete RPMI with the respective growth factors.

Infection of DC and M1/M2 Macrophages

On day 7, non-adherent and loosely adherent DC were harvested by gentle up and down pipetting movements. M1/M2-like macrophages were detached with 5 mM EDTA. Afterwards, cells were seeded in 96-well plates and infected with each strain using a multiplicity of infection (MOI) of 1:5 or 1:10 (human cell: bacteria) and incubated at 37°C and 5% CO2. After 2 h of incubation, 50 μg/ml gentamicin (AppliChem) was added to stop bacterial growth and the plates were again incubated at 37°C and 5% CO2 for 24 h. After the incubation period, the plates were centrifuged (300g, 10 min), the supernatants collected and stored at −80°C for cytokines quantification. In the case of DC, after supernatant collection, the cells were stained for flow cytometry cell surface activation detection.

Quantification of Cytokine Production

Cytokine levels in cell culture supernatants were evaluated by sandwich ELISA using commercial kits, according to the manufacturer’s instructions (TNF-α, IL-6, IL-8, IL-10, and IL-12p70 DuoSet® ELISA Development System—R&D Systems).

Evaluation of DC Activation

To assess the expression of cell surface activation markers, DC were collected 24 h after infection with S. epidermidis strains, washed and incubated with fixable viability dye (eFluor 780) and with cell-surface antibodies, anti-human CD11c-APC conjugated (clone BU15), anti-human HLA-PECy7 conjugated (clone L243), anti-human CD83-FITC conjugated (clone HB15e), anti-human CD14-PE-conjugated (clone 61D3), anti-human CD80-BV510 conjugated (clone 2D10), and anti-human CD86-PECy5 conjugated (clone IT2.2), all purchased from eBiosciences. Cells were fixed with paraformaldehyde and resuspended in FACS buffer. Samples were analyzed by flow cytometry, using BD FACSCanto™ II and data analysis was performed using FlowJo™ 10.7.1 Software (BD Life Sciences), using the gating strategy represented in Supplementary Figure 1B.

Ethics Statement

Human blood was collected in heparin-coated tubes (Vacuette), from adult healthy volunteers under a protocol approved by the Institutional Review Board of the University of Minho [SECVS 002/2014 (ADENDA)]. Buffy coats from healthy adult blood donors, used for M1/M2 macrophages and DC differentiation, were acquired at the Immunohemoterapy Department of Centro Hospitalar de São João (Porto, Portugal), under ethical approval of the service (Protocol reference 260/11). All procedures were performed in agreement with the Helsinki declaration and Oviedo convention and all donors gave written consent before blood collection.

Statistical Analysis

Statistical analysis was performed using either unpaired T-test with Welch’s correction or One-way ANOVA with Tukey’s multiple comparisons test, using GraphPad Prism version 7 (Trial version, CA, USA). P-values below 0.05 were considered significant.

Results

mazEF Homologue Mutation and Complementation

The deletion of mazEF homologue in S. epidermidis strain 1457 was successfully achieved as confirmed by PCR and qPCR (Supplementary Figure 2), originating the mutant strain ΔmazEF. We then complemented the mutant with mazEF homologue sequence using the plasmid pRB473. The presence of the plasmid was confirmed by PCR (Supplementary Figure 3A) and the expression of the genes was confirmed by qPCR (Supplementary Figure 2). In addition, qPCR analysis confirmed that mazEF homologue deletion did not significantly interfere with rsbU regulation (Donegan and Cheung, 2009; Schuster et al., 2015) and that the plasmid pRB473 + mazEF restored mazEF homologue expression (Supplementary Figure 2). Moreover, the mutant strain was also complemented with mazE, mazF or mazEF homologous sequences using the inducible plasmid pRMC2 (Supplementary Figure 3B) required for the toxin–antitoxin experiments, further described below.

Role of mazEF Homologue in VBNC State Induction in S. epidermidis 1457

Based on the previous hypothesis that mazEF could be involved in VBNC state modulation in S. epidermidis biofilms, the proportions of VBNC cells in biofilms formed by the WT, ΔmazEF, and ΔmazEF::pRB473 strains were characterized using three techniques: OD, to evaluate the amount of total cells (Figure 1A), flow cytometry, to quantify total live cells (Figure 1B), and CFU counting, to determine the number of culturable cells (Figure 1C). No differences were observed in all strains tested, suggesting that mazEF did not have a significant role in VBNC state induction. We then assessed if there was any structural difference in the biofilms formed by these strains. However, as shown by the CLSM analysis (Figure 1D), no differences in biofilms structure were found.

FIGURE 1
www.frontiersin.org

Figure 1 The role of mazEF homologue on the regulation of the VBNC state in S. epidermidis 1457 48-hour old biofilms. Quantification of S. epidermidis biofilms grown under VBNC inducing conditions in terms of (A) Total amount of cells (OD); (B) Concentration of live cells (flow cytometry); and (C) Concentration of culturable cells (CFU/ml). Results are represented as the mean + standard deviation of at least 3 independent experiments. Statistical analysis was performed with One-way ANOVA with Tukey’s multiple comparisons test, **p <0.01,***p <0.001. (D) Biofilm structure analysis assessed by CLSM. The images shown are representative of 2 independent experiments. PRE, Prevented VBNC; IND, Induced VBNC.

Role of mazEF Homologue in S. epidermidis 1457 Virulence Potential

Although our data do not support that mazEF homologue has an important role in VBNC state modulation in biofilms, we further explored the role of this operon in S. epidermidis 1457 general virulence. For that, the mutant strain complemented with the target genes and their natural promoter (ΔmazEF::pRB473+mazEF) was used to try to mimic the level of transcription in the WT strain.

As shown in Figure 2A, all strains presented a similar growth rate in the planktonic mode of growth. When analyzing the expression of genes putatively linked with VBNC cells formation (pdhA, codY, and clpP) (Carvalhais et al., 2014), and also related to biofilm formation (icaA) (Heilmann et al., 1996a; Heilmann et al., 1996b), we observed that the mutant had approximately a 3-fold increase in the expression of the gene codY, although some variability was observed among assays and no statistical significance was reached (Figure 2B). Regarding antimicrobial tolerance of biofilms (Figure 2C), minor differences in cells culturability were detected between the mutant and WT, but none were statistically significant. Interestingly, when evaluating biofilm cells metabolism, we observed that tetracycline was significantly more effective against the WT strain (Supplementary Figure 4). Furthermore, the same assays were repeated for planktonic cultures but, again, no substantial differences were found among strains (Supplementary Figure 5). Finally, when analyzing the ability to survive in human blood and plasma, similar results were obtained among strains at either earlier (1 and 2 h) (Supplementary Figure 6) or later (4 h) time points (Figure 2D).

FIGURE 2
www.frontiersin.org

Figure 2 Characterization of the role of mazEF homologue constructs in S. epidermidis 1457 phenotype and virulence potential. (A) Growth curve of S. epidermidis strains as determined by optical density (OD 640 nm); (B) Fold-change expression in 48 hour-old biofilms formed by all strains. The values obtained in the WT strain were used as control. Each point represents a single experiment and the horizontal lines the mean of at least 5 independent experiments; (C) Effect of rifampicin (RIF) and tetracycline (TET) on the culturability of 48-hour old biofilm cells. Results are presented as the LOG difference between the control samples (no antibiotic) and the antibiotic-treated samples (ΔLOG); (D) Survival of S. epidermidis strains in human blood and plasma upon 4 h of incubation. Each point is relative to a different donor/assay and the horizontal lines represent the median of 6 independent experiments performed with different donors (3 females and 3 males). TSB supplemented with heparin (TSB + Heparin) was used to evaluate the effect of heparin on bacterial growth. Results (A, C) are presented as the mean + standard deviation of at least 3 independent assays. Statistical analysis was performed using One-way ANOVA with Tukey’s multiple comparisons test for all the assays.

Despite the lack of compelling differences in the ability of the strains to survive in human blood and plasma, we also assessed if the mazEF homologue could have an impact on the response of macrophages and DC when challenged with S. epidermidis. As shown in Figure 3, similar results were detected in the production of pro- (IL-12, IL-6, IL-8, and TNF) or anti-inflammatory (IL-10) cytokines by M1- and M2-like macrophages or DC when stimulated with different multiplicities of infection (MOI 1:5, Figure 3 or MOI 1:10, Supplementary Figure 7).

FIGURE 3
www.frontiersin.org

Figure 3 Effect of mazEF homologue deletion in the response of mononuclear phagocytes. (A–E) Quantification of the cytokines secreted by human monocyte-derived M1- and M2-type macrophages (M1 and M2) and dendritic cells (DC) in cell-culture supernatants upon incubation with S. epidermidis cells at a MOI of 1 M1/M2/DC:5 bacteria. (F) Cell surface expression of activation/maturation markers detected by flow cytometry on DC upon incubation with S. epidermidis cells at a MOI of 1 DC:5 bacteria. Cytokine levels and activation marker expression are presented as fold-changes to the respective values of positive control (LPS) samples. Bars correspond to means + standard deviation of at least 3 independent experiments, where each condition was set in duplicate. Statistical analysis was performed using One-way ANOVA with Tukey’s multiple comparison test. HLA, human leukocyte antigen.

Role of mazEF Homologue as a Putative TA System

Since mazEF operon has been described, either experimentally or by homology, as a TA system in some staphylococcal species, we aimed to experimentally investigate if it has the same function in S. epidermidis 1457. After successful transformation of pRMC2 plasmids, the expression of the target genes was induced with either tetracycline (TET) or anhydrotetracycline (ATC), aiming to assess the best concentration to induce expression but without interfering with the culturability of ΔmazEF cells. While TET caused a slight reduction in the number of culturable cells compared to the control (no antibiotic), the ATC did not significantly affect cells culturability (Figure 4A). To ensure that mazE/F/EF homologues were being expressed under the selected inducing conditions (0.64 μg/ml of ATC), a qPCR analysis was performed and showed that mazEF homologous genes were being significantly expressed (Figure 4B). To analyze the putative role of mazEF as a TA system in S. epidermidis, the amount of total cells, as determined by OD, and the number of culturable cells, as determined by CFU counting, was assessed in the mutant and the complemented strains upon induction of mazE/mazF/mazEF homologues expression. However, in our conditions, no significant differences were observed in the OD (Figures 4C, D) or cells culturability (Supplementary Table 3).

FIGURE 4
www.frontiersin.org

Figure 4 Study of the putative TA action of mazEF homologue. (A) Growth curve of ΔmazEF planktonic cells upon incubation with different concentrations of anhydrotetracycline (ATC) and tetracycline (TET). The control (CT) data refers to non-induced cells. The data presented are relative to a single assay; (B) Fold-change expression of the mazEF homologue genes upon 4 h of induction with ATC 0.64 μg/ml. ΔmazEF cells harboring the inducible plasmids but without induction were used as control. Each point represents a single experiment and the horizontal lines represent the mean of 6 independent experiments; (C) Optical density (OD) of the control strains; and (D) strains induced with 0.64 μg/ml of ATC. Results are represented as the mean + standard deviation of at least 3 independent assays (C, D). Statistical analysis was completed with One-way ANOVA with Tukey’s multiple comparisons test (B–D).

Discussion

The mazEF operon was initially identified as a TA system in E. coli, and then further confirmed in other gram-negative and gram-positive bacteria, with homology studies suggesting that this operon could have a TA function also in S. epidermidis. Importantly, although the homology between S. epidermidis 1457 mazEF homologue operon and E. coli is not very high (about 40% of nucleotide and 22 to 36% amino acid homology), greater homology was found with S. aureus strain Newman (Supplementary Table 4), where mazEF has been recently confirmed to function as a TA system (Ma et al., 2019). Interestingly, other biological roles have been linked with mazEF. Recently, mazEF increased expression was associated with P. aeruginosa and some staphylococcal species higher tolerance to gentamicin, ciprofloxacin, and clindamycin (Coskun et al., 2018). Furthermore, a role in biofilm formation and evasion from the host system was also described in S. aureus (Ma et al., 2019).

In S. epidermidis, preliminary evidence suggesting that mazEF homologue could play an important role in virulence came from previous transcriptomics studies, where it was suggested that the mazEF homologue could be involved in the regulation of the VBNC state in biofilms (Carvalhais et al., 2014). As such, we started by evaluating if the mazEF homologue mutant could impact the proportion of VBNC cells. VBNC cell formation in S. epidermidis biofilms is not universal, showing high variability among strains (Carvalhais et al., 2018). We recently confirmed that strain 1457 can form VBNC cells (Gaio et al., 2021), however, at a lower extent than previously tested strains (Carvalhais et al., 2018). Moreover, we observed that the expression of mazEF genes in biofilms grown under VBNC state inducing conditions was lower in 1457 than in other strains (Gaio et al., 2021). As such, it was not surprising that the lack of mazEF homologue did not significantly affect VBNC cells formation in S. epidermidis 1457, but we can’t exclude that in some clinical strains where the VBNC state is more pronounced, mazEF could play a role. Interestingly, the deletion of the mazEF homologue led to an increased expression of the gene codY, which has been also proposed to play a role in VBNC cells formation in S. epidermidis biofilms (Carvalhais et al., 2014). These results suggest that this gene may be compensating for the effect of the mazEF homologue absence, but this should be further explored. Other relevant genes, namely genes associated with biofilm formation, such as icaA and rsbU (Heilmann et al., 1996a; Heilmann et al., 1996b; Knobloch et al., 2004) were not affected by the mazEF homologue deletion.

We then further explored if the deletion of the mazEF homologue operon could influence other phenotypical traits in S. epidermidis. When assessing the response of planktonic and biofilm cells to vancomycin, rifampicin, and tetracycline, we observed that biofilm cells lacking mazEF homologue showed a significantly lower metabolic activity, after 6 h of treatment. This was an interesting result since it was previously shown that tetracycline might enhance the development of VBNC cells in S. epidermidis biofilms (Carvalhais et al., 2018). However, despite the change in metabolism, we did not observe any significant difference in bacterial culturability. Moreover, no differences in the bacterial survival in human blood or plasma were detected, as well as no relevant alterations in the levels of cytokines produced by M1- and M2-like macrophages or DC upon incubation with the distinct strains. This suggests that the deletion of mazEF homologue does not have a direct impact on the activation of the cells studied, which is usually driven by bacterial cell wall components.

Finally, considering the proximal relation and close homology to S. aureus, we also investigated the possible role of mazEF homologue operon as a TA module. In our experimental conditions, mazEF homologue did not seem to act as a TA system in S. epidermidis strain 1457. Despite the many similar traits between S. aureus and S. epidermidis, it was previously shown that the regulation of some important genes associated with biofilm formation is different, notwithstanding their significant homology (Cerca et al., 2008).

Altogether, in this brief report we performed the first characterization of a mazEF homologue mutant and demonstrated that, at least in strain 1457, the mazEF homologue does not seem to have a major role in S. epidermidis virulence potential.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Ethics Statement

Human blood was collected in heparin-coated tubes (Vacuette), from adult healthy volunteers under a protocol approved by the Institutional Review Board of the University of Minho (SECVS 002/2014 (ADENDA)). Buffy coats from healthy adult blood donors, used for M1/M2 macrophages and DC differentiation, were acquired at the Immunohemoterapy Department of Centro Hospitalar de São João (Porto, Portugal), under ethical approval of the service (Protocol reference 260/11). All procedures were performed in agreement with the Helsinki declaration and Oviedo convention and all donors gave written consent before blood collection.

Author Contributions

Conceptualization, MV, NC, and AF. Investigation, VG and TL. Writing original draft, VG and AF. Writing—review and editing, NC, TL, and MV. Supervision, MV, NC, and AF. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the Portuguese Foundation for Science and Technology (FCT) by the funder project PTDC/BIA-MOL/29553/2017, under the scope of COMPETE2020 (POCI-01-0145-FEDER-029553) and by the strategic funding unit UIDB/04469/2020. VG acknowledges the support of FCT individual fellowship [SFRH/BD/131452/2017].

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We thank Tim Foster for kindly providing the plasmid pRMC2.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2021.803134/full#supplementary-material

References

Anderson, G. G., O’Toole, G. A. (2008). Innate and Induced Resistance Mechanisms of Bacterial Biofilms. Curr. Top. Microbiol. Immunol. 322, 85–105. doi: 10.1007/978-3-540-75418-3_5

PubMed Abstract | CrossRef Full Text | Google Scholar

Behrooz, S. K., Lida, L., Ali, S., Mehdi, M., Rasoul, M., Elnaz, O., et al. (2018). Study of MazEF, Sam, and Phd-Doc Putative Toxin-Antitoxin Systems in Staphylococcus Epidermidis. Acta Microbiol. Immunol. Hung. 65, 1–11. doi: 10.1556/030.65.2018.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Brás, S., França, A., Cerca, N. (2020). Optimizing a Reliable Ex Vivo Human Blood Model to Analyze Expression of Staphylococcus Epidermidis Genes. PeerJ 8, e9295. doi: 10.7717/peerj.9295

PubMed Abstract | CrossRef Full Text | Google Scholar

Brescó, M. S., Harris, L. G., Thompson, K., Stanic, B., Morgenstern, M., O’Mahony, L., et al. (2017). Pathogenic Mechanisms and Host Interactions in Staphylococcus Epidermidis Device-Related Infection. Front. Microbiol. 8, 1401. doi: 10.3389/fmicb.2017.01401

PubMed Abstract | CrossRef Full Text | Google Scholar

Brückner, R. (1997). Gene Replacement in Staphylococcus Carnosus and Staphylococcus Xylosus. FEMS Microbiol. Lett. 151, 1–8. doi: 10.1016/S0378-1097(97)00116-X

PubMed Abstract | CrossRef Full Text | Google Scholar

Bruckner, R., Wagner, E., Gotz, F. (1993). Characterization of a Sucrase Gene From Staphylococcus Xylosus. J. Bacteriol. 175 (3), 851–857. doi: 10.1128/jb.175.3.851-857.1993

PubMed Abstract | CrossRef Full Text | Google Scholar

Carvalhais, V., França, A., Cerca, F., Vitorino, R., Pier, G. B., Vilanova, M., et al. (2014). Dormancy Within Staphylococcus Epidermidis Biofilms: A Transcriptomic Analysis by RNA-Seq. Appl. Microbiol. Biotechnol. 98, 1–12. doi: 10.1007/s00253-014-5548-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Carvalhais, V., Pérez-Cabezas, B., Oliveira, C., Vitorino, R., Vilanova, M., Cerca, N. (2018). Tetracycline and Rifampicin Induced a Viable But Nonculturable State in Staphylococcus Epidermidis Biofilms. Future Microbiol. 13, 27–36. doi: 10.2217/fmb-2017-0107

PubMed Abstract | CrossRef Full Text | Google Scholar

Cerca, F., Andrade, F., França, A., Andrade, E. B., Ribeiro, A., Almeida, A. A., et al. (2011a). Staphylococcus Epidermidis Biofilms With Higher Proportions of Dormant Bacteria Induce a Lower Activation of Murine Macrophages. J. Med. Microbiol. 60, 1717–1724. doi: 10.1099/jmm.0.031922-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Cerca, N., Brooks, J. L., Jefferson, K. K. (2008). Regulation of the Intercellular Adhesin Locus Regulator (Icar) by SarA, ςb, and IcaR in Staphylococcus Aureus. J. Bacteriol. 190 (19), 6530–6533. doi: 10.1128/JB.00482-08

PubMed Abstract | CrossRef Full Text | Google Scholar

Cerca, F., França, A., Perez-Cabezas, B., Carvalhais, V., Ribeiro, A., Azeredo, J., et al. (2014). Dormant Bacteria Within Staphylococcus Epidermidis Biofilms Have Low Inflammatory Properties and Maintain Tolerance to Vancomycin and Penicillin After Entering Planktonic Growth. J. Med. Microbiol. 63, 1274–1283. doi: 10.1099/jmm.0.073163-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Cerca, N., Jefferson, K. K., Oliveira, R., Pier, G. B., Azeredo, J. (2006). Comparative Antibody-Mediated Phagocytosis of Staphylococcus Epidermidis Cells Grown in a Biofilm or in the Planktonic State. Infect. Immun. 74, 4849–4855. doi: 10.1128/IAI.00230-06

PubMed Abstract | CrossRef Full Text | Google Scholar

Cerca, N., Martins, S., Cerca, F., Jefferson, K. K., Pier, G. B., Oliveira, R., et al. (2005). Comparative Assessment of Antibiotic Susceptibility of Coagulase-Negative Staphylococci in Biofilm Versus Planktonic Culture as Assessed by Bacterial Enumeration or Rapid XTT Colorimetry. J. Antimicrob. Chemother. 56, 331–336. doi: 10.1093/jac/dki217

PubMed Abstract | CrossRef Full Text | Google Scholar

Cerca, F., Trigo, G., Correia, A., Cerca, N., Azeredo, J., Vilanova, M. (2011b). SYBR Green as a Fluorescent Probe to Evaluate the Biofilm Physiological State of Staphylococcus Epidermidis, Using Flow Cytometry. Can. J. Microbiol. 57, 850–856. doi: 10.1139/w11-078

PubMed Abstract | CrossRef Full Text | Google Scholar

Corrigan, R. M., Foster, T. J. (2009). An Improved Tetracycline-Inducible Expression Vector for Staphylococcus Aureus. Plasmid 61 (2), 126–129. doi: 10.1016/j.plasmid.2008.10.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Coskun, U. S. S., Cicek, A. C., Kilinc, C., Guckan, R., Dagcioglu, Y., Demir, O., et al. (2018). Effect of MazEF, HigBA and RelBE Toxin-Antitoxin Systems on Antibiotic Resistance in Pseudomonas Aeruginosa and Staphylococcus Isolates. Malawi Med. J. 30 (2), 67–72. doi: 10.4314/mmj.v30i2.3

PubMed Abstract | CrossRef Full Text | Google Scholar

Cui, B., Smooker, P. M., Rouch, D. A., Deighton, M. A. (2015). Enhancing DNA Electro-Transformation Efficiency on a Clinical Staphylococcus Capitis Isolate. J. Microbiol. Methods 109, 25–30. doi: 10.1016/j.mimet.2014.11.012

PubMed Abstract | CrossRef Full Text | Google Scholar

Donegan, N. P., Cheung, A. L. (2009). Regulation of the mazEF Toxin-Antitoxin Module in Staphylococcus Aureus and Its Impact on sigB Expression. J. Bacteriol. 191, 2795–2805. doi: 10.1128/JB.01713-08

PubMed Abstract | CrossRef Full Text | Google Scholar

Fey, P. D., Olson, M. E. (2011). Current Concepts in Biofilm Formation of Staphylococcus Epidermidis. Future Microbiol. 5, 917–933. doi: 10.2217/fmb.10.56.Current

CrossRef Full Text | Google Scholar

França, A., Freitas, A. I., Henriques, A. F., Cerca, N. (2012). Optimizing a qPCR Gene Expression Quantification Assay for S. Epidermidis Biofilms: A Comparison Between Commercial Kits and a Customized Protocol. PloS One 7, e37480. doi: 10.1371/journal.pone.0037480

PubMed Abstract | CrossRef Full Text | Google Scholar

França, A., Pier, G. B., Vilanova, M., Cerca, N. (2016). Transcriptomic Analysis of Staphylococcus Epidermidis Biofilm-Released Cells Upon Interaction With Human Blood Circulating Immune Cells and Soluble Factors. Front. Microbiol. 7, 1143. doi: 10.3389/fmicb.2016.01143

PubMed Abstract | CrossRef Full Text | Google Scholar

Freitas, A. I., Vasconcelos, C., Vilanova, M., Cerca, N. (2014). Optimization of an Automatic Counting System for the Quantification of Staphylococcus Epidermidis Cells in Biofilms. J. Basic Microbiol. 54, 750–757. doi: 10.1002/jobm.201200603

PubMed Abstract | CrossRef Full Text | Google Scholar

Gaio, V., Lopes, N., Cerca, N., França, A. (2021). codY and pdhA Expression is Induced in Staphylococcus Epidermidis Biofilm and Planktonic Populations With Higher Proportions of Viable But non-Culturable Cells. Front. Cell. Infect. Microbiol. 11, 771666. doi: 10.3389/fcimb.2021.771666

PubMed Abstract | CrossRef Full Text | Google Scholar

Heilmann, C., Gerke, C., Perdreau-Remington, F., Götz, F. (1996a). Characterization of Tn917 Insertion Mutants of Staphylococcus Epidermidis Affected in Biofilm Formation. Infect. Immun. 64, 277–282. doi: 10.1128/iai.64.1.277-282.1996

PubMed Abstract | CrossRef Full Text | Google Scholar

Heilmann, C., Schweitzer, O., Gerke, C., Vanittanakom, N., Mack, D., Götz, F. (1996b). Molecular Basis of Intercellular Adhesion in the Biofilm-Forming Staphylococcus Epidermidis. Mol. Microbiol. 20 (5), 1083–1091. doi: 10.1111/j.1365-2958.1996.tb02548.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Karimi, S., Ghafourian, S., Kalani, M. T., Jalilian, F. A., Hemati, S., Sadeghifard, N. (2015). Association Between Toxin-Antitoxin Systems and Biofilm Formation. Jundishapur J. Microbiol. 8, 1–6. doi: 10.5812/jjm.14540

CrossRef Full Text | Google Scholar

Knobloch, J. K. M., Jäger, S., Horstkotte, M. A., Rohde, H., Mack, D. (2004). RsbU-Dependent Regulation of Staphylococcus Epidermidis Biofilm Formation is Mediated via the Alternative Sigma Factor ςb by Repression of the Negative Regulator Gene icaR. Infect. Immun. 72, 3838–3848. doi: 10.1128/IAI.72.7.3838-3848.2004

PubMed Abstract | CrossRef Full Text | Google Scholar

Mack, D., Siemssen, N., Laufs, ,. R. (1992). Parallel Induction by Glucose of Adherence and a Polysaccharide Antigen Specific for Plastic-Adherent Staphylococcus Epidermidis: Evidence for Functional Relation to Intercellular Adhesion. Infect. Immun. 60, 2048–2057. doi: 10.1128/iai.60.5.2048-2057.1992

PubMed Abstract | CrossRef Full Text | Google Scholar

Ma, D., Mandell, J. B., Donegan, N. P., Cheung, A. L., Ma, W., Rothenberger, S., et al. (2019). The Toxin-Antitoxin mazEF Drives Staphylococcus Aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection. MBio 10 (6), e01658–19. doi: 10.1128/mBio.01658-19

PubMed Abstract | CrossRef Full Text | Google Scholar

Metzger, S., Dror, I. B., Aizenman, E., Schreiber, G., Toone, M., Friesen, J. D., et al. (1988). The Nucleotide Sequence and Characterization of the relA Gene of Escherichia Coli. J. Biol. Chem. 263, 15699–15704. doi: 10.1111/j.1574-6968.1996.tb08317.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Monk, I. R., Shah, I. M., Xu, M. (2012). Transforming the Untransformable: Application of Direct Transformation to Manipulate Genetically Staphylococcus Aureus and Staphylococcus Epidermidis. MBio 3, e00277–e00211. doi: 10.1128/mBio.00277-11.Editor

PubMed Abstract | CrossRef Full Text | Google Scholar

Nguyen, T. H., Park, M. D., Otto, M. (2017). Host Response to Staphylococcus Epidermidis Colonization and Infections. Front. Cell. Infect. Microbiol 7, 90. doi: 10.3389/fcimb.2017.00090

PubMed Abstract | CrossRef Full Text | Google Scholar

Oliveira, F., Lima, C. A., Bras, S., França, A., Cerca, N. (2015). Evidence for Inter- and Intraspecies Biofilm Formation Variability Among a Small Group of Coagulase-Negative Staphylococci. FEMS Microbiol. Lett. 362, 1–20. doi: 10.1093/femsle/fnv175

CrossRef Full Text | Google Scholar

Otto, M. (2009). Staphylococcus Epidermidis – the “Accidental” Pathogen. Nat. Rev. Microbiol. 7, 555–567. doi: 10.1038/nrmicro2182.Staphylococcus

PubMed Abstract | CrossRef Full Text | Google Scholar

Schuster, C. F., Mechler, L., Nolle, N., Krismer, B., Zelder, M. E., Götz, F., et al. (2015). The mazEF Toxin-Antitoxin System Alters the β-Lactam Susceptibility of Staphylococcus Aureus. PloS One 10, 1–22. doi: 10.1371/journal.pone.0126118

CrossRef Full Text | Google Scholar

Schuster, C. F., Park, J. H., Prax, M., Herbig, A., Nieselt, K., Rosenstein, R., et al. (2013). Characterization of a MazEF Toxin-Antitoxin Homologue From Staphylococcus Equorum. J. Bacteriol. 195, 115–125. doi: 10.1128/JB.00400-12

PubMed Abstract | CrossRef Full Text | Google Scholar

Shapiro, J. A., Nguyen, V. L., Chamberlain, N. R. (2011). Evidence for Persisters in Staphylococcus Epidermidis RP62A Planktonic Cultures and Biofilms. J. Med. Microbiol. 60, 950–960. doi: 10.1099/jmm.0.026013-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Sousa, C., França, A., Cerca, N. (2014). Assessing and Reducing Sources of Gene Expression Variability in Staphylococcus Epidermidis Biofilms. Biotechniques 57, 295–301. doi: 10.2144/000114238

PubMed Abstract | CrossRef Full Text | Google Scholar

Syed, M. A., Koyanagi, S., Sharma, E., Jobin, M. C., Yakunin, A. F., Lévesque, C. M. (2011). The Chromosomal mazEF Locus of Streptococcus Mutans Encodes a Functional Type II Toxin-Antitoxin Addiction System. J. Bacteriol. 193 (5), 1122–1130. doi: 10.1128/JB.01114-10

PubMed Abstract | CrossRef Full Text | Google Scholar

Tiwari, P., Arora, G., Singh, M., Kidwai, S., Narayan, O. P., Singh, R. (2015). MazF Ribonucleases Promote Mycobacterium Tuberculosis Drug Tolerance and Virulence in Guinea Pigs. Nat. Commun. 6, 6059. doi: 10.1038/ncomms7059

PubMed Abstract | CrossRef Full Text | Google Scholar

Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B. C., Remm, M., et al. (2012). Primer3 - New Capabilities and Interfaces. Nucleic Acids Res. 40, e115. doi: 10.1093/nar/gks596

PubMed Abstract | CrossRef Full Text | Google Scholar

Valadbeigi, H., Sadeghifard, N., Salehi, M. B. (2017). Assessment of Biofilm Formation in Pseudomonas Aeruginosa by Antisense mazE-PNA. Microb. Pathog. 104, 28–31. doi: 10.1016/j.micpath.2017.01.009

PubMed Abstract | CrossRef Full Text | Google Scholar

Van Melderen, L. (2010). Toxin-Antitoxin Systems: Why So Many, What for? Curr. Opin. Microbiol. 13, 781–785. doi: 10.1016/j.mib.2010.10.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Zandri, G., Pasquaroli, S., Vignaroli, C., Talevi, S., Manso, E., Donelli, G., et al. (2012). Detection of Viable But non-Culturable Staphylococci in Biofilms From Central Venous Catheters Negative on Standard Microbiological Assays. Clin. Microbiol. Infect. 18, 259–261. doi: 10.1111/j.1469-0691.2012.03893.x

CrossRef Full Text | Google Scholar

Zhu, L., Inoue, K., Yoshizumi, S., Kobayashi, H., Zhang, Y., Ouyang, M., et al. (2009). Staphylococcus Aureus MazF Specifically Cleaves a Pentad Sequence, UACAU, Which is Unusually Abundant in the mRNA for Pathogenic Adhesive Factor SraP. J. Bacteriol. 191, 3248–3255. doi: 10.1128/JB.01815-08

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: SERP1681, SERP1682, antimicrobial tolerance, biofilms, human blood, human plasma, macrophages, dendritic cells

Citation: Gaio V, Lima T, Vilanova M, Cerca N and França A (2022) mazEF Homologue Has a Minor Role in Staphylococcus epidermidis 1457 Virulence Potential. Front. Cell. Infect. Microbiol. 11:803134. doi: 10.3389/fcimb.2021.803134

Received: 27 October 2021; Accepted: 06 December 2021;
Published: 13 January 2022.

Edited by:

Lauren O Bakaletz, Nationwide Children’s Hospital, United States

Reviewed by:

Fernanda Buzzola, CONICET Research Institute in Microbiology and Medical Parasitology (IMPaM), Argentina
Ferdinand Xiankeng Choong, Karolinska Institutet (KI), Sweden
Timothy J. Foster, Trinity College Dublin, Ireland

Copyright © 2022 Gaio, Lima, Vilanova, Cerca and França. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Angela França, YWZyYW5jYUBjZWIudW1pbmhvLnB0

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.